This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Liver cirrhosis is a serious, irreversible condition in which healthy liver tissue is replaced with scar tissue, caused by long-term damage to the liver. It is a progressive disease that can be caused by a variety of factors, including viral infections, alcohol abuse, or fatty liver disease. The most common symptoms of cirrhosis include fatigue, weight loss, jaundice, and abdominal pain. The liver is responsible for filtering and detoxifying the blood, and when scar tissue replaces healthy liver tissue, it can become too damaged to perform its vital functions. This can lead to a build-up of toxins in the blood, and can cause serious health problems such as internal bleeding, fluid accumulation, and liver failure. Diagnosis of cirrhosis is typically made through a physical exam, blood tests, and imaging tests such as ultrasound or CT scan. Treatment may include lifestyle changes such as cutting back on alcohol and avoiding certain medications, and in more serious cases, a liver transplant may be necessary. Prevention of cirrhosis is key, and includes avoiding excessive alcohol consumption, staying up-to-date on vaccinations, and maintaining a healthy weight. Early diagnosis and treatment is also important, as it can help slow the progression of the disease. If you have any of the symptoms of cirrhosis or suspect you may be at risk, it is important to talk to your doctor.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States